The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
The Complex Role of Angiopoietin-2 in the Angiopoietin-Tie Signaling Pathway
Open accessAbstract
The angiopoietin-Tie signaling system is a vascular-specific receptor tyrosine kinase pathway that is essential for normal vascular development. Although the basic functioning of the pathway is understood, many uncertainties remain about the role of certain members of the pathway, particularly angiopoietin-2 (Ang2), in pathological vascular remodeling and angiogenesis. We summarize the components of the angiopoietin-Tie pathway and then focus on studies that highlight the role of Ang2 in disease settings, including cancer and inflammation. The expression of Ang2 is elevated in many cancers and types of inflammation, which prompted the development of specific reagents to block its interaction with the Tie2 receptor. The application of these reagents in preclinical models of inflammation and cancer has begun to elucidate the role of Ang2 in vascular remodeling and disease pathogenesis and has led to emerging clinical tests of Ang2 inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,847
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W., & Qin, Y. (1995) · Nature · doi:10.1038/376070a0 · Cited by 1,820
Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
Augustin, H. G., Young Koh, G., Thurston, G., & Alitalo, K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2639 · Cited by 1,465
Self-citationLeakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1
Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T. N., Yancopoulos, G. D., & McDonald, D. M. (1999) · Science · doi:10.1126/science.286.5449.2511 · Cited by 1,359
Self-citationAngiopoietin-1 protects the adult vasculature against plasma leakage
Thurston, G., Rudge, J. S., Ioffe, E., Zhou, H., Ross, L., Croll, S. D., Glazer, N., Holash, J., McDonald, D. M., & Yancopoulos, G. D. (2000) · Nature Medicine · doi:10.1038/74725 · Cited by 1,297
Self-citationSignaling Vascular Morphogenesis and Maintenance
Hanahan, D. (1997) · Science · doi:10.1126/science.277.5322.48 · Cited by 1,190
Gale, N. W., Thurston, G., Hackett, S. F., Renard, R., Wang, Q., McClain, J., Martin, C., Witte, C., Witte, M. H., Jackson, D., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00217-4 · Cited by 1,018
Self-citationDumont, D. J., Gradwohl, G., Fong, G. H., Puri, M. C., Gertsenstein, M., Auerbach, A., & Breitman, M. L. (1994) · Genes & Development · doi:10.1101/gad.8.16.1897 · Cited by 985
Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N. W., Witzenrath, M., Rosseau, S., Suttorp, N., et al. (2006) · Nature Medicine · doi:10.1038/nm1351 · Cited by 933
Self-citationIncreased Vascularization in Mice Overexpressing Angiopoietin-1
Suri, C., McClain, J., Thurston, G., McDonald, D. M., Zhou, H., Oldmixon, E. H., Sato, T. N., & Yancopoulos, G. D. (1998) · Science · doi:10.1126/science.282.5388.468 · Cited by 818
Self-citationVascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2
Vikkula, M., Boon, L. M., Iii, K. L. C., Calvert, J. T., Diamonti, A. J., Goumnerov, B., Pasyk, K. A., Marchuk, D. A., Warman, M. L., Cantley, L. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81814-0 · Cited by 802
Holash, J., Wiegand, S. J., & Yancopoulos, G. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203035 · Cited by 744
Fiedler, U., Scharpfenecker, M., Koidl, S., Hegen, A., Grunow, V., Schmidt, J. M., Kriz, W., Thurston, G., & Augustin, H. G. (2004) · Blood · doi:10.1182/blood-2003-10-3685 · Cited by 742
Self-citationKim, I., Kim, H. G., So, J.-N., Kim, J. H., Kwak, H. J., & Koh, G. Y. (2000) · Circulation Research · doi:10.1161/01.res.86.1.24 · Cited by 649
Puri, M. C., Rossant, J., Alitalo, K., Bernstein, A., & Partanen, J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00276.x · Cited by 519
Gamble, J. R., Drew, J., Trezise, L., Underwood, A., Parsons, M., Kasminkas, L., Rudge, J., Yancopoulos, G., & Vadas, M. A. (2000) · Circulation Research · doi:10.1161/01.res.87.7.603 · Cited by 505
Limaye, N., Wouters, V., Uebelhoer, M., Tuominen, M., Wirkkala, R., Mulliken, J. B., Eklund, L., Boon, L. M., & Vikkula, M. (2009) · Nature Genetics · doi:10.1038/ng.272 · Cited by 492
Stratmann, A., Risau, W., & Plate, K. H. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65733-1 · Cited by 485
Saharinen, P., Eklund, L., Miettinen, J., Wirkkala, R., Anisimov, A., Winderlich, M., Nottebaum, A., Vestweber, D., Deutsch, U., Koh, G. Y., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1715 · Cited by 471
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2
Oliner, J., Min, H., Leal, J., Yu, D., Rao, S., You, E., Tang, X., Kim, H., Meyer, S., Han, S. J., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.030 · Cited by 471
Sato, T. N., Qin, Y., Kozak, C. A., & Audus, K. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9355 · Cited by 462
Fukuhara, S., Sako, K., Minami, T., Noda, K., Kim, H. Z., Kodama, T., Shibuya, M., Takakura, N., Koh, G. Y., & Mochizuki, N. (2008) · Nature Cell Biology · doi:10.1038/ncb1714 · Cited by 387
Mandriota, S. J., & Pepper, M. S. (1998) · Circulation Research · doi:10.1161/01.res.83.8.852 · Cited by 381
Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
Lin, P., Buxton, J. A., Acheson, A., Radziejewski, C., Maisonpierre, P. C., Yancopoulos, G. D., Channon, K. M., Hale, L. P., Dewhirst, M. W., George, S. E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8829 · Cited by 371
Kim, I., Moon, S.-O., Park, S. K., Chae, S. W., & Koh, G. Y. (2001) · Circulation Research · doi:10.1161/hh1801.097034 · Cited by 370
Hyperoxia causes angiopoietin 2–mediated acute lung injury and necrotic cell death
Bhandari, V., Choo-Wing, R., Lee, C. G., Zhu, Z., Nedrelow, J. H., Chupp, G. L., Zhang, X., Matthay, M. A., Ware, L. B., Homer, R. J., et al. (2006) · Nature Medicine · doi:10.1038/nm1494 · Cited by 337
Daly, C., Wong, V., Burova, E., Wei, Y., Zabski, S., Griffiths, J., Lai, K.-M., Lin, H. C., Ioffe, E., Yancopoulos, G. D., et al. (2004) · Genes & Development · doi:10.1101/gad.1189704 · Cited by 327
Self-citationKim, I., Kim, J.-H., Moon, S.-O., Kwak, H. J., Kim, N.-G., & Koh, G. Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203800 · Cited by 306
Teichert-Kuliszewska, K. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00231-5 · Cited by 291
COMP-Ang1: A designed angiopoietin-1 variant with nonleaky angiogenic activity
Cho, C.-H., Kammerer, R. A., Lee, H. J., Steinmetz, M. O., Ryu, Y. S., Lee, S. H., Yasunaga, K., Kim, K.-T., Kim, I., Choi, H.-H., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307574101 · Cited by 257
Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells
Daly, C., Pasnikowski, E., Burova, E., Wong, V., Aldrich, T. H., Griffiths, J., Ioffe, E., Daly, T. J., Fandl, J. P., Papadopoulos, N., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607538103 · Cited by 251
Self-citationComplementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth
Hashizume, H., Falcón, B. L., Kuroda, T., Baluk, P., Coxon, A., Yu, D., Bready, J. V., Oliner, J. D., & McDonald, D. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1977 · Cited by 251
Davis, S., Papadopoulos, N., Aldrich, T. H., Maisonpierre, P. C., Huang, T., Kovac, L., Xu, A., Leidich, R., Radziejewska, E., Rafique, A., et al. (2003) · Nature Structural Biology · doi:10.1038/nsb880 · Cited by 234
Saharinen, P., Kerkelä, K., Ekman, N., Marron, M., Brindle, N., Lee, G. M., Augustin, H., Koh, G. Y., & Alitalo, K. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200411105 · Cited by 233
Falcón, B. L., Hashizume, H., Koumoutsakos, P., Chou, J., Bready, J. V., Coxon, A., Oliner, J. D., & McDonald, D. M. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090391 · Cited by 224
Zagzag, D., Hooper, A., Friedlander, D. R., Chan, W., Holash, J., Wiegand, S. J., Yancopoulos, G. D., & Grumet, M. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7162 · Cited by 222
Protective Role of Angiopoietin-1 in Endotoxic Shock
Witzenbichler, B., Westermann, D., Knueppel, S., Schultheiss, H.-P., & Tschope, C. (2005) · Circulation · doi:10.1161/01.cir.0000151287.08202.8e · Cited by 202
Angiopoietin-2 Levels Are Associated with Disease Progression in Metastatic Malignant Melanoma
Helfrich, I., Edler, L., Sucker, A., Thomas, M., Christian, S., Schadendorf, D., & Augustin, H. G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1615 · Cited by 201
Suppression of Diabetic Retinopathy with Angiopoietin-1
Joussen, A. M., Poulaki, V., Tsujikawa, A., Qin, W., Qaum, T., Xu, Q., Moromizato, Y., Bursell, S.-E., Wiegand¶, S. J., Rudge, J., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61115-7 · Cited by 198
VE-PTP controls blood vessel development by balancing Tie-2 activity
Winderlich, M., Keller, L., Cagna, G., Broermann, A., Kamenyeva, O., Kiefer, F., Deutsch, U., Nottebaum, A. F., & Vestweber, D. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200811159 · Cited by 189
Goede, V, Coutelle, O., Neuneier, J., Reinacher-Schick, A., Schnell, R., Koslowsky, T. C., Weihrauch, M. R., Cremer, B., Kashkar, H., Odenthal, M., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605925 · Cited by 186
Nasarre, P., Thomas, M., Kruse, K., Helfrich, I., Wolter, V., Deppermann, C., Schadendorf, D., Thurston, G., Fiedler, U., & Augustin, H. G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3030 · Cited by 181
Self-citationJho, D., Mehta, D., Ahmmed, G., Gao, X.-P., Tiruppathi, C., Broman, M., & Malik, A. B. (2005) · Circulation Research · doi:10.1161/01.res.0000171894.03801.03 · Cited by 171
Bäumer, S., Keller, L., Holtmann, A., Funke, R., August, B., Gamp, A., Wolburg, H., Wolburg-Buchholz, K., Deutsch, U., & Vestweber, D. (2006) · Blood · doi:10.1182/blood-2006-01-0141 · Cited by 158
Brown, J. L., Cao, Z. A., Pinzon-Ortiz, M. C., Kendrew, J., Reimer, C., Wen, S., Zhou, J. Q., Tabrizi, M. A., Emery, S. C., McDermott, B., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0554 · Cited by 154
Coxon, A., BREADY, J. V., Min, H., Kaufman, S., Leal, J., Yu, D., Lee, T. A., Sun, J.-R., Estrada, J., Bolon, B. N., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0213 · Cited by 152
Brown, L. F., Dezube, B. J., Tognazzi, K., Dvorak, H. F., & Yancopoulos, G. D. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65088-2 · Cited by 146
Thrombin Induces the Release of Angiopoietin-1 from Platelets
Li, J.-J., Huang, Y.-Q., Basch, R. S., & Karpatkin, S. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615677 · Cited by 146
Dominguez, M. G., Hughes, V. C., Li, P., Simmons, M. V., Daly, C., Anderson, K., Noguera‐Troise, I., Murphy, A. J., Valenzuela, D. M., Davis, S. H., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611510104 · Cited by 145
Self-citationVEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects
Duda, D. G., Batchelor, T. T., Willett, C. G., & Jain, R. K. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.04.001 · Cited by 145
Huang, H., Lai, J.-Y., Do, J., Liu, D., Li, L., Rosario, J. D., Doppalapudi, V. R., Pirie-Shepherd, S. R., Levin, N., Bradshaw, C. W., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2317 · Cited by 142
Baffert, F., Thurston, G., Rochon-Duck, M., Le, T., Brekken, R. A., & McDonald, D. M. (2004) · Circulation Research · doi:10.1161/01.res.0000125295.43813.1f · Cited by 132
Self-citationXu, Y., & Yu, Q. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103661200 · Cited by 117
Yuan, H. T., Venkatesha, S., Chan, B., Deutsch, U., Mammoto, T., Sukhatme, V. P., Woolf, A. S., & Karumanchi, S. A. (2007) · The FASEB Journal · doi:10.1096/fj.07-8487com · Cited by 116
Thurston, G., Wang, Q., Baffert, F., Rudge, J. S., Papadopoulos, N. J., Jean-Guillaume, D., Wiegand, S. J., Yancopoulos, G. D., & McDonald, D. M. (2005) · Development · doi:10.1242/dev.01888 · Cited by 110
Self-citationDavis, J. S., Yeo, T. W., Piera, K. A., Woodberry, T., Celermajer, D. S., Stephens, D. P., & Anstey, N. M. (2010) · Critical Care · doi:10.1186/cc9020 · Cited by 108
Tumor Necrosis Factor-α Upregulates Angiopoietin-2 in Human Umbilical Vein Endothelial Cells
Kim, I., Kim, J.-H., Ryu, Y. S., Liu, M., & Koh, G. Y. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2296 · Cited by 105
Angiopoietin-2 Promotes Disease Progression of Neuroendocrine Tumors
Detjen, K. M., Rieke, S., Deters, A., Schulz, P. M., Rexin, A., Vollmer, S., Hauff, P., Wiedenmann, B. J., Pavel, M., & Scholz, A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1924 · Cited by 87
The angiopoietin-Tie2 system as a therapeutic target in sepsis and acute lung injury
van der Heijden, M., Amerongen, G. P. V. N., Chedamni, S., van Hinsbergh, V. W. M., & Groeneveld, A. B. J. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220802626256 · Cited by 76
Scholz, A., Rehm, V. A., Rieke, S., Derkow, K., Schulz, P. M., Neumann, K., Koch, I., Pascu, M., Wiedenmann, B., Berg, T., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01377.x · Cited by 74
Angiopoietin-2-Driven Vascular Remodeling in Airway Inflammation
Tabruyn, S. P., Colton, K., Morisada, T., Fuxe, J., Wiegand, S. J., Thurston, G., Coyle, A. J., Connor, J. R., & McDonald, D. M. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100059 · Cited by 67
Self-citationLi, X., Hahn, C. N., Parsons, M., Drew, J., Vadas, M. A., & Gamble, J. R. (2004) · Blood · doi:10.1182/blood-2003-11-3744 · Cited by 63
Li, Z., Huang, H., Boland, P. S., Dominguez, M. G., Burfeind, P., Lai, K. V., Lin, H.-C., Gale, N. W., Daly, C., Auerbach, W., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911189106 · Cited by 35
Self-citationNykänen, A. I., Pajusola, K., Krebs, R., Keränen, M. A. I., Raisky, O., Koskinen, P., Alitalo, K. K., & Lemström, K. (2006) · Circulation Research · doi:10.1161/01.res.0000225987.52765.13 · Cited by 34
Moon, W. S., Park, H. S., Yu, K. H., Jang, K. Y., Kang, M. J., Park, H., & Tarnawski, A. S. (2006) · Journal of Korean Medical Science · doi:10.3346/jkms.2006.21.2.272 · Cited by 30
Fuxe, J., Lashnits, E. W., O’Brien, S., Bałuk, P., Tabruyn, S. P., Kuhnert, F., Kuo, C. J., Thurston, G., & McDonald, D. M. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090976 · Cited by 29
Self-citationLocalization of the VEGF and angiopoietin genes in uterine carcinosarcoma
Emoto, M., Jones, D. S., Licence, D. R., Ishiguro, M., Kawai, M., Yanaihara, A., Saito, T., Hachisuga, T., Iwasaki, H., Kawarabayashi, T., et al. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.08.042 · Cited by 27
Differential expression of the Tie-2 receptor and its ligands in human pancreatic tumors
Durkin, A. J., Bloomston, M., Yeatman, T. J., Gilbert‐Barness, E., Cojita, D., Rosemurgy, A. S., & Zervos, E. E. (2004) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2004.07.021 · Cited by 27
Cited by
Macrophage Polarization States in the Tumor Microenvironment
Boutilier, A. J., & Elsawa, S. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136995 · Cited by 1,631
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
Therapeutic targeting of the angiopoietin–TIE pathway
Saharinen, P., Eklund, L., & Alitalo, K. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.278 · Cited by 620
Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology
Akwii, R. G., Sajib, M. S., Zahra, F. T., & Mikelis, C. M. (2019) · Cells · doi:10.3390/cells8050471 · Cited by 543
Passing the Vascular Barrier: Endothelial Signaling Processes Controlling Extravasation
Wettschureck, N., Strilic, B., & Offermanns, S. (2019) · Physiological Reviews · doi:10.1152/physrev.00037.2018 · Cited by 286
Metadata
- Authors
- Thurston, G., & Daly, C.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-04-10
- Volume
- 2
- Issue
- 9
- Pages
- a006650-a006650
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2129790740
- Cited by
- 266
- References
- 70
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.